Bilcare Research
Home  |  Media  |  Contact Us
Increase text size Restore default text size Decrease text size
Bilcare in News Media Kit Events Image GalleryDownload Center Media Contact

Press Releases

November 29, 2010

INEOS Films becomes Bilcare Research as of 1st December 2010

Click here to download PDF (English)

Click here to download PDF (German)

Click here to download PDF (Italian)

Staufen, Germany - November 29, 2010 INEOS Films Group announced today the completion of its legal name change. With effect of 1st December 2010 INEOS Films will become Bilcare Research.

The existing portfolios of Bilcare Films and Foils and INEOS Films will be merged into the new group, which will become a full range solution provider. The newly appointed Management is currently engaged in putting a new strategy into action.

“Broad investments in marketing, production and R&D will ensure that we continue to be a leading global manufacturer of films and become a full range solution provider for our customers”, said Dr. Heinz Gaertner, Chairman Bilcare Research AG.

The branding of the businesses will be modified as follows:

  • Cards Business will become Cards Solutions
  • Packaging Business will become Packaging Films Solutions
  • Pharma Business will become Pharma Packaging Innovations
  • Specialties Business will become Specialty Films Solutions

The website address will change to

For Cards Solutions the global approach with production facilities in Italy and the US will be strengthened, offering new developments from Bilcare Singapore Technology Center, such as nonClonableIDTM label technologies and biodegradable plastics.

Packaging Films Solutions will set up a new strategy, also offering PET films and laminated films, using the production facilities in Germany, India, Italy, Singapore and the US. Investments will be made especially in the lamination.

Pharma Packaging Innovations will step up to become a full range solution provider, integrating the existing Bilcare Films and Aluminium-Foils business. Significant investments in extending coating capacities are already implemented. Further investments to develop new markets have been initiated.

Specialty Films Solutions will offer additional high quality print films in doubling capacities especially for matt surfaces. With an investment in a combined PET extrusion / shrink center, Bilcare Research will provide high shrink PET films solutions, complementing PVC shrink grades.

The names of the legal entities will be changed as follows:

  • Bilcare AG will become Bilcare Research AG
  • Bilcare Italia S.r.l., formerly INEOS Films Italia S.r.l., will become Bilcare Research S.r.l.
  • Bilcare Italia Films S.r.l., formerly INEOS Films S.p.a., will become Bilcare Fucine S.r.l.
  • INEOS Films GmbH will become Bilcare Research GmbH
  • INEOS Films Staufen GmbH will become Bilcare Staufen GmbH
  • INEOS Films Inc. will become Bilcare Research Inc.

Media Contact:

Daniela Mutterer
Bilcare Research
Phone: +49 7633 811 240

Bilcare Research
Phone: +91 20 30257700

Note to the Editors:

Bilcare Research Films Business ( is a global producer of rigid films. Its manufacturing and marketing activity is concentrated in the production of rigid PVC and PVC-PE films and includes the finishing of films in the form of coating, stentering, laminating and metallizing. It is also involved in the extrusion of PET and PET-PE films. With over 50 years experience in the production of rigid films, the Bilcare Research Films Business today is one of the leading rigid film producers in the world. Worldwide the Films Group employs approximately 1,300 people with sites in Germany, Italy, India and the USA. It has the capacity to produce around 140,000 tonnes of films per annum and had sales of EUR 240 million in 2009.

Bilcare ( Bilcare Ltd. (BSE code 526853) is an international, integrated service provider to the global pharmaceutical industry offering Pharma packaging & research, global clinical trial supplies services and Bilcare Technologies offering nonClonableID™ identification, authentication, secure track-n-trace anti-counterfeiting technology. Bilcare operates state-of-the-art manufacturing and research facilities in India, Singapore, USA and UK and has regional offices in Brazil, Germany, China and Australia. Bilcare provides solutions that address many of the industry’s key concerns including counterfeit drugs, compliance, costs, communication and convenience.

© , Bilcare Limited. All Rights Reserved. Disclaimer Site Map Privacy Policy Content + Design Riteverses